Misoprostol for second trimester pregnancy termination in women with prior caesarean section.
OBJECTIVE
To examine whether a previous caesarean section increases the risk for complications in women undergoing a mid-trimester pregnancy termination by labour induction.


METHODS
Retrospective analysis of case records between 1997 and 2002.


METHODS
Fetal Medicine Unit of a large teaching hospital.


METHODS
One hundred and eight women with a previous caesarean section (study group) and 216 women without such a history (controls), who underwent a second trimester termination of pregnancy.


METHODS
All the terminations were performed between 17 and 24 weeks of gestation by using 400 mug of oral administration of misoprostol in combination with 400 mug of intravaginal misoprostol. The same dose of intravaginal misoprostol was repeated every 6 hours for a maximum of five doses.


METHODS
Severe haemorrhage requiring blood transfusion, post-abortal infection, retained placenta and uterine rupture.


RESULTS
Complications occurred in 16 out of 108 women of the study group (15%) and in 26 out of 216 of the controls (12%), with only one ruptured uterus in the control group.


CONCLUSIONS
We found no evidence that a previous caesarean delivery affects the incidence of complications when women with such a history undergo a mid-trimester pregnancy termination with misoprostol.
Daskalakis
George J
GJ
First Department of Obstetrics and Gynaecology, Fetal Medicine Unit, Alexandra Hospital, University of Athens, Greece.
Mesogitis
Spyros A
SA
Papantoniou
Nikolaos E
NE
Moulopoulos
George G
GG
Papapanagiotou
Angeliki A
AA
Antsaklis
Aris J
AJ
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D012189:Retrospective Studies; D012307:Risk Factors
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol